After potential exposure to Hepatitis B, which management step is appropriate?

After potential exposure to Hepatitis B, which management step is appropriate?

• A. Observation only
• B. Testing and possible post-exposure prophylaxis
• C. Immediate vaccination without testing
• D. No action unless symptoms appear

Answer: (B)

After exposure to hepatitis B, act quickly to determine the person’s immune status and whether they have begun or could begin an infection. The main idea is to use testing to guide targeted prevention rather than guessing or waiting for symptoms. Serologic testing helps distinguish current infection (HBsAg), immunity from vaccination (anti-HBs), and prior exposure (anti-HBc). A person’s vaccination history also matters. If the patient is not immune or their status is unknown, post-exposure prophylaxis should be started because it can prevent establishing infection. This typically involves the hepatitis B vaccine series and, in many situations, hepatitis B immune globulin (HBIG) given as soon as possible, ideally within seven days of exposure. If the person has completed the vaccine series and is known to have a protective response, PEP may not be needed, but confirming immunity with anti-HBs testing is still important. Choosing to observe without intervention is risky because HBV can be transmitted during exposure and early prophylaxis significantly lowers the chance of infection. Vaccinating blindly without assessing immune status can be inappropriate if the person is already immune or currently infected. Waiting for symptoms is not acceptable because HBV infection can be asymptomatic initially, and early prophylaxis is more effective.

After exposure to hepatitis B, act quickly to determine the person’s immune status and whether they have begun or could begin an infection. The main idea is to use testing to guide targeted prevention rather than guessing or waiting for symptoms. Serologic testing helps distinguish current infection (HBsAg), immunity from vaccination (anti-HBs), and prior exposure (anti-HBc). A person’s vaccination history also matters.

If the patient is not immune or their status is unknown, post-exposure prophylaxis should be started because it can prevent establishing infection. This typically involves the hepatitis B vaccine series and, in many situations, hepatitis B immune globulin (HBIG) given as soon as possible, ideally within seven days of exposure. If the person has completed the vaccine series and is known to have a protective response, PEP may not be needed, but confirming immunity with anti-HBs testing is still important.

Choosing to observe without intervention is risky because HBV can be transmitted during exposure and early prophylaxis significantly lowers the chance of infection. Vaccinating blindly without assessing immune status can be inappropriate if the person is already immune or currently infected. Waiting for symptoms is not acceptable because HBV infection can be asymptomatic initially, and early prophylaxis is more effective.